Factors affecting the precision of lesion sizing with contrast-enhanced spectral mammography
To evaluate the precision of the pre-surgical measurement of the size of breast cancer by contrast-enhanced spectral mammography (CESM).
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Enhancing the diagnosis of breast cancer is the stated goal of a research team at the German Cancer Research Center (DKFZ) in Heidelberg. The scientists have combined an advanced method of diffusion-weighted MR imaging with intelligent image analysis methods to detect malignant changes in tissues. This method may help avoid many control biopsies following suspicious findings from mammography screening. This advancement holds promise for substantial improvements in the diagnosis of breast cancer.
Women with disabilities (WWD) have reported lower mammography rates than the general population, however rates for women with cerebral palsy (CP) have not been specifically studied.
Women who get magnetic resonance imaging (MRI) screening tests for breast cancer are more likely to get invasive surgical biopsies to look for tumors than women who just get screening mammograms, a U.S. study suggests.Reuters Health Information
CONCLUSION: These results could justify the conservative management, in a selected group of patients, being the malignancy rate lower than 2%, considered in the literature as the "probably benign" definition. Advances in knowledge: Increasing the length of follow-up of selected patients conservatively managed can improve the management of ADH cases. PMID: 29451396 [PubMed - as supplied by publisher]
(Reuters Health) - Women who get magnetic resonance imaging (MRI) screening tests for breast cancer are more likely to get invasive surgical biopsies to look for tumors than women who just get screening mammograms, a U.S. study suggests.
Abstract Mammographic breast density is an established risk factor for breast cancer and significantly reduces the sensitivity of mammography, yet its use within breast cancer screening programs in Australia is limited. We provide a contemporary snapshot of the role of breast density measurement in screening for breast cancer and review the recent evidence for an increasing role of breast density measurement as: a predictor of breast cancer risk, a predictor of 'masking', and a biomarker to monitor effectiveness of intervention strategies for primary prevention or improved breast cancer outcomes. PMID: 294470...
ConclusionMBI seems to be a useful imaging modality with a high predictive value in revealing ipsilateral and bilateral disease not visualized by mammography and ultrasound. It may play an important role in delineating the extent of the index lesion during preoperative planning. Incorporation of MBI in the clinical work-up as an adjunct modality to mammography and ultrasound may lead to better selection of patients who could benefit from BCS.
CONCLUSION: Providing quadrant view is used in addition to full field view, there is no significant difference in cancer detection between the 8MP monitor and the pair of 5MP monitors. Advances in knowledge: Effect of magnification on the detectability of subtle malignant calcification clusters in breast screening. PMID: 29436850 [PubMed - as supplied by publisher]
(Georgetown University Medical Center) Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in aging women -- those ages 65 and older. The findings of a new study could impact mammography screening decisions later in life.
This population-based cohort study uses cancer registry data to examine the biopsy rates and yield in the 90 days following screening (mammography vs MRI with or without mammography) among women with and without a personal history of breast cancer.